Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving Tamoxifen

Completed · Phase 2

Conditions studied: Breast Cancer, Menopausal Symptoms

In brief

RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about differences in DNA and predict how well patients will respond to treatment and plan better treatment. PURPOSE: This clinical trial is studying blood samples from women with breast cancer or ductal carcinoma in situ who are receiving tamoxifen.

Key facts

Study ID

NCT00764322

Run by

UNC Lineberger Comprehensive Cancer Center

People needed

501

Starts

2008-06-18

Expected to finish

2011-07-01

Last updated by the study team

2017-08-01

Who can join

Age: 21 and older, up to 120. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill — Chapel Hill, North Carolina, United States
• Blumenthal Cancer Center at Carolinas Medical Center — Charlotte, North Carolina, United States
• Duke Comprehensive Cancer Center — Durham, North Carolina, United States
• Moses Cone Regional Cancer Center at Wesley Long Community Hospital — Greensboro, North Carolina, United States
• Leo W. Jenkins Cancer Center at ECU Medical School — Greenville, North Carolina, United States
• Rex Cancer Center at Rex Hospital — Raleigh, North Carolina, United States
• Gibbs Regional Cancer Center at Spartanburg Regional Medical Center — Spartanburg, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.